<p>Biomedical research has long been dedicated to elucidating the determinants of human health and disease. The interaction between intrinsic and environmental factors that affect the metabolic, immune, nervous, and endocrine systems has been the focus of many efforts in the field. Yet, redox signaling, which involves the fine modulation of molecular pathways by free radicals and oxidants, is emerging as a unifying theme in the pathophysiology of human diseases [<span>[1, 2]</span>].</p><p>Biological oxidants are a chemically and biologically diverse group of molecules derived from molecular oxygen, nitrogen, or sulfur (although this could be extended to include other elements such as carbon, selenium, halogens, and electrophile species that undergo redox reactions) with critical signaling functions under physiological conditions, ensuring what has been coined by Helmut Sies as oxidative eustress [<span>[3]</span>]. Dysregulation of redox homeostasis results in supra-physiological concentrations of these species, which establish non-specific reactions with biomolecules and generate other, more reactive species with the ability to react indiscriminately with most biomolecules, producing what is commonly refered to as oxidative (dis)stress [<span>[4]</span>]. The transition from oxidative eustress to oxidative distress is a common observation in several pathophysiological conditions [<span>[3, 4]</span>]. As such, cells strategically employ several defense systems, including enzymes and low molecular weight antioxidants, to maintain redox homeostasis. Sensing systems detect shifts from the steady-state oxidant level and initiate appropriate defense strategies. Important redox hubs worth mentioning include NRF2, NF-κB, HIF, ERR, FOXO, PGC1α, AMPK, GAPDH, and UCP, all of which are regulated via oxidation of Cys residues either on adaptor proteins or on the transcription factor itself (reviewed in [<span>[5, 6]</span>]).</p><p>Superoxide radical (<span></span><math>